Inhibrx Biosciences, Inc.
INBX
$88.37
-$8.64-8.91%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/11/2026
-
MarketBeat
8/14/2026
-
Tickeron - Stocks
8/14/2026
-
MarketBeat
Inhibrx Biosciences (NASDAQ:INBX) Posts Quarterly Earnings Results, Misses Expectations By $0.06 EPS
8/13/2026
-
MarketBeat
8/13/2026
-
PR Newswire
8/13/2026
-
Tickeron - Stocks
8/13/2026
-
Tickeron - Stocks
8/9/2026
-
MarketBeat
8/6/2026
-
Tickeron - Stocks
8/5/2026
-
MarketBeat
7/31/2026
-
Tickeron - Stocks
Healthcare of Ontario Pension Plan Trust Fund Sells 93,300 Shares of Inhibrx Biosciences, Inc. $INBX
7/29/2026
-
MarketBeat
7/27/2026
-
MarketBeat
7/25/2026
-
SeekingAlpha
7/23/2026
-
Simply Wall St
7/20/2026
-
The Cerbat Gem
7/20/2026
-
MarketBeat
7/17/2026
-
SeekingAlpha
7/17/2026
-
Seeking Alpha - Healthcare
7/16/2026
-
PR Newswire
7/16/2026
-
Tickeron - Stocks
7/15/2026
-
Tickeron - Stocks
7/12/2026
-
MarketBeat
7/10/2026
-
MarketBeat
7/10/2026
-
Simply Wall St
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, May 14, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
858 795 4220
Address
11025 North Torrey Pines Road
Suite 140
La Jolla, CA 92037
Suite 140
La Jolla, CA 92037
Country
Year Founded
Business Description
Sector
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates...
more